For years, much of 'women's' athletic footwear has been, in practice, a scaled-down, recoloured version of the men's model. But the female foot has different proportions —a narrower heel, a different forefoot, distinct gait needs—. Treating that as a simple size scaling leaves a real pain point unresolved.
The woman who runs or walks and looks for footwear that genuinely fits her well, without discomfort, with a focus on comfort and foot health, finds surprisingly limited options. It is not a marginal niche: it is a huge and growing part of the market, served with product designed for another foot.
The opportunity is not only aesthetic. Real widths, measurable fit, materials that reduce discomfort and a foot-health narrative —not a marketing one— connect with a consumer willing to pay an accessible premium for something that works for her. 'Comfort' stops being a catalogue word and becomes the central proposition.
The giants are optimised for volume and the generic runner; pivoting towards a specific women's last with a comfort focus is neither their priority nor their advantage. That leaves room for a focused brand that makes that pain point its reason for being. The key: the fit must be verifiable (low returns, high recommendation), not a promise.
In our report we analyse this niche as the central strategic recommendation: women's running/walking with a width option and a comfort focus, alongside the metrics (returns, NPS) that determine whether the proposition genuinely works.